Skip to main content
SpringerLink
Log in

Immunoglobulins and sepsis

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Shankar-Hari M, Spencer J, Sewell WA, Rowan KM, Singer M (2012) Bench-to-bedside review: immunoglobulin therapy for sepsis—biological plausibility from a critical care perspective. Crit Care 16:206

    Article  Google Scholar 

  2. Shankar-Hari M, Culshaw N, Post B, Tamayo E, Andaluz-Ojeda D, Bermejo-Martin JF, Dietz S, Werdan K, Beale R, Spencer J, Singer M (2015) Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med 41:1393–1401

    Article  CAS  Google Scholar 

  3. Shankar-Hari M, Singer M, Spencer J (2017) Can Concurrent abnormalities in free light chains and immunoglobulin concentrations identify a target population for immunoglobulin trials in sepsis? Crit Care Med 45:1829–1836

    Article  CAS  Google Scholar 

  4. Bermejo-Martin JF, Rodriguez-Fernandez A, Herran-Monge R, Andaluz-Ojeda D, Muriel-Bombin A, Merino P, Garcia-Garcia MM, Citores R, Gandia F, Almansa R, Blanco J, Group G (2014) Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med 276:404–412

    Article  CAS  Google Scholar 

  5. Martin-Loeches I, Muriel-Bombin A, Ferrer R, Artigas A, Sole-Violan J, Lorente L, Andaluz-Ojeda D, Prina-Mello A, Herran-Monge R, Suberviola B, Rodriguez-Fernandez A, Merino P, Loza AM, Garcia-Olivares P, Anton E, Tamayo E, Trapiello W, Blanco J, Bermejo-Martin JF, group G (2017) The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure. Ann Intensive Care 7:44

    Article  Google Scholar 

  6. Giamarellos-Bourboulis EJ, Apostolidou E, Lada M, Perdios I, Gatselis NK, Tsangaris I, Georgitsi M, Bristianou M, Kanni T, Sereti K, Kyprianou MA, Kotanidou A, Armaganidis A, Hellenic Sepsis Study Group (2013) Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care 17:R247

    Article  Google Scholar 

  7. Nakano T, Matsui M, Inoue I, Awata T, Katayama S, Murakoshi T (2011) Free immunoglobulin light chain: its biology and implications in diseases. Clin Chim Acta 412:843–849

    Article  CAS  Google Scholar 

  8. Shankar-Hari M, Fear D, Lavender P, Mare T, Beale R, Swanson C, Singer M, Spencer J (2017) Activation-associated accelerated apoptosis of memory B cells in critically ill patients with sepsis. Crit Care Med 45:875–882

    Article  Google Scholar 

  9. Soares MO, Welton NJ, Harrison DA, Peura P, Shankar- Hari M, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM (2012) An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 16:1–186

    Article  CAS  Google Scholar 

  10. Turgeon AF, Hutton B, Fergusson DA, McIntyre L, Tinmouth AA, Cameron DW, Hebert PC (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146:193–203

    Article  Google Scholar 

  11. Shankar-Hari M, Harrison DA, Rowan KM (2016) Differences in impact of definitional elements on mortality precludes international comparisons of sepsis epidemiology-a cohort study illustrating the need for standardized reporting. Crit Care Med 44:2223–2230

    Article  Google Scholar 

  12. Burnham KL, Davenport EE, Radhakrishnan J, Humburg P, Gordon AC, Hutton P, Svoren-Jabalera E, Garrard C, Hill AVS, Hinds CJ, Knight JC (2017) Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia. Am J Respir Crit Care Med 196:328–339

    Article  CAS  Google Scholar 

  13. Shankar-Hari M, Rubenfeld GD (2017) The use of enrichment to reduce statistically indeterminate or negative trials in critical care. Anaesthesia 72:560–565

    Article  CAS  Google Scholar 

  14. Giamarellos-Bourboulis EJ, Tziolos N, Routsi C, Katsenos C, Tsangaris I, Pneumatikos I, Vlachogiannis G, Theodorou V, Prekates A, Antypa E, Koulouras V, Kapravelos N, Gogos C, Antoniadou E, Mandragos K, Armaganidis A, Hellenic Sepsis Study Group (2016) Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins. Clin Microbiol Infect 22:499–506

    Article  CAS  Google Scholar 

  15. Ishikura H, Nakamura Y, Kawano Y, Tanaka J, Mizunuma M, Ohta D, Nishida T, Murai A (2015) Intravenous immunoglobulin improves sepsis-induced coagulopathy: a retrospective, single-center observational study. J Crit Care 30:579–583

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Shankar-Hari is supported by the National Institute for Health Research Clinician Scientist Award (CS-2016-16-011). Dr. Turgeon is the Canada Research Chair in Critical Care Neurology and Trauma and is supported by the Canadian Institutes of Health Research. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.

Author information

Authors and Affiliations

  1. Guy’s and St Thomas’ NHS Foundation Trust, ICU Support Offices, St Thomas’ Hospital, 1st Floor, East Wing, SE1 7EH, UK

    Manu Shankar-Hari

  2. School of Immunology and Microbial Sciences, Kings College London, London, SE1 9RT, UK

    Manu Shankar-Hari

  3. Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

    Martin Bruun Madsen

  4. Division of Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, QC, Canada

    Alexis F. Turgeon

  5. Population Health and Optimal Health Practices Research Unit (Trauma-Trauma-Emergency-Critical Care Medicine), CHU de Québec-Université Laval Research Center (Enfant-Jésus Hospital), Québec City, QC, Canada

    Alexis F. Turgeon

Authors
  1. Manu Shankar-Hari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Bruun Madsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexis F. Turgeon
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors developed the outline. MSH wrote the first draft. All authors contributed to the critical revision of the manuscript for important intellectual content.

Corresponding author

Correspondence to Manu Shankar-Hari.

Ethics declarations

Conflicts of interest

The Department of Intensive Care, Rigshospitalet, receives support for research from CSL Behring, Ferring Pharmaceuticals and Fresenius Kabi. MS-H’s department acknowledges receipt of honoraria from Biotest for two talks MSH given at meetings.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shankar-Hari, M., Madsen, M.B. & Turgeon, A.F. Immunoglobulins and sepsis. Intensive Care Med 44, 1923–1925 (2018). https://doi.org/10.1007/s00134-018-5047-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-018-5047-6

Keywords

Search

Navigation